agilon health (NYSE:AGL) Sees Unusually-High Trading Volume – Here’s What Happened

agilon health, inc. (NYSE:AGL) shares saw an uptick in trading volume on Tuesday . 6,150,804 shares were traded during mid-day trading, an increase of 27% from the previous session’s volume of 4,856,478 shares.The stock last traded at $3.45 and had previously closed at $3.42.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Macquarie initiated coverage on shares of agilon health in a research note on Monday, December 16th. They set a “neutral” rating and a $3.00 price target on the stock. Royal Bank of Canada restated an “outperform” rating and set a $3.00 target price on shares of agilon health in a research report on Tuesday, November 19th. TD Cowen cut their price target on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. William Blair cut agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Finally, JMP Securities lowered agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat, agilon health currently has an average rating of “Hold” and an average price target of $4.03.

agilon health Stock Up 1.3 %

The firm’s 50-day moving average price is $2.77 and its 200-day moving average price is $3.12. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The company has a market cap of $1.49 billion, a price-to-earnings ratio of -3.85 and a beta of 0.67.

Insider Buying and Selling at agilon health

In other news, Director Karen Mcloughlin purchased 25,000 shares of the stock in a transaction that occurred on Friday, December 13th. The stock was acquired at an average cost of $2.20 per share, with a total value of $55,000.00. Following the acquisition, the director now owns 73,166 shares in the company, valued at approximately $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director John William Wulf purchased 45,000 shares of the company’s stock in a transaction that occurred on Thursday, December 5th. The shares were purchased at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the purchase, the director now directly owns 206,133 shares in the company, valued at $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 90,000 shares of company stock valued at $198,100 over the last three months. 3.20% of the stock is owned by company insiders.

Institutional Trading of agilon health

Several large investors have recently modified their holdings of the business. Captrust Financial Advisors boosted its holdings in agilon health by 10.9% in the fourth quarter. Captrust Financial Advisors now owns 35,485 shares of the company’s stock valued at $67,000 after purchasing an additional 3,494 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of agilon health by 2.5% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 206,991 shares of the company’s stock valued at $393,000 after purchasing an additional 5,107 shares in the last quarter. MetLife Investment Management LLC boosted its stake in shares of agilon health by 4.0% during the 4th quarter. MetLife Investment Management LLC now owns 174,551 shares of the company’s stock valued at $332,000 after buying an additional 6,762 shares during the last quarter. Symphony Financial Services Inc. grew its position in shares of agilon health by 44.3% during the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock worth $44,000 after buying an additional 7,058 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of agilon health during the third quarter worth approximately $28,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.